Cerity Partners’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,348
Closed -$20.6K 2505
2024
Q3
$20.6K Buy
+10,348
New +$20.6K ﹤0.01% 2512
2020
Q4
Sell
-35,600
Closed -$528K 649
2020
Q3
$528K Sell
35,600
-2,438
-6% -$36.2K 0.02% 315
2020
Q2
$560K Buy
38,038
+2,438
+7% +$35.9K 0.03% 267
2020
Q1
$418K Sell
35,600
-850
-2% -$9.98K 0.03% 303
2019
Q4
$857K Buy
36,450
+1,370
+4% +$32.2K 0.04% 259
2019
Q3
$649K Buy
35,080
+10,080
+40% +$186K 0.04% 284
2019
Q2
$465K Sell
25,000
-90
-0.4% -$1.67K 0.03% 330
2019
Q1
$613K Buy
+25,090
New +$613K 0.04% 301